Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley MarketBeat
Covered in this story
Tracked from this story
Morgan Stanley’s $177 target on $MRK is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Morgan Stanley’s track record →Analyst targets on Merck & Co.
- JPMorgan: $140 → $165 by Oct 2027 · Overweight via MarketBeat
- Scotiabank: $149 → $180 by Sep 2027 · sector outperform via marketbeat.com
- Wolfe Research: $156 → $180 by Aug 2027 via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Merck & Co. →Dalsna Finance is currently tracking 30 stories mentioning Merck & Co., the earliest published 10 Jul 2026.
Summary aggregated from MarketBeat's public RSS feed. The full reporting belongs to MarketBeat — please read it on their site.